4//SEC Filing
Anacor Pharmaceuticals, Inc. 4
Accession 0001209191-16-125860
CIK 0001411158operating
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 9:00 PM ET
Size
4.8 KB
Accession
0001209191-16-125860
Insider Transaction Report
Form 4
Bell Graeme
Executive VP and CFO
Transactions
- Sale
Common Stock
2016-06-01$99.28/sh−751$74,559→ 10,255 total
Footnotes (1)
- [F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person to cover taxes associated with the vesting of restricted stock units.
Documents
Issuer
Anacor Pharmaceuticals, Inc.
CIK 0001411158
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411158
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 9:00 PM ET
- Size
- 4.8 KB